Tender Details

Country: USA
Summary: Drug Manufacturing and Formulation Program
UST Ref No: 95765870
Deadline: 07 Feb 2024
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: NIH-NINDS-SB-75N95023R00031
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Description
This is a Small Business Sources Sought notice. This is NOT a solicitation or request for proposals, proposal abstracts, or quotations. It is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice. This notice is strictly for the purpose of obtaining information and identifying organizations that have the capability to perform a prospective research and development requirement which is described in the attached Statement of Work. The Government will NOT be responsible for any costs incurred by any respondent to this notice.

Once a determination is made regarding the method of acquisition, a separate pre-solicitation notice will be issued.

Background: The National Institutes of Health (NIH) established the Blueprint Neurotherapeutics Network (BPN) to bridge the gap in drug development between academic and industry research. The BPN supports, through grants and contracts, every step of the drug development process, from validated hits through Phase I clinical trials. The Drug Manufacturing and Formulation Program (DMFP), a component of the BPN, will include contractors who will conduct the development and manufacture of dosage forms of small molecule drug candidates suitable for administration in preclinical efficacy studies, Investigational New Drug (IND) enabling studies, and clinical trials.

Purpose/Objective: The National Institute of Neurological Disorders and Stroke (NINDS) is seeking to identify organizations with the requisite qualifications and capabilities to provide services including determine the availability of small business organizations that have the capability to conduct process development and preparation of active pharmaceutical ingredients (API), pre-formulation and formulation studies, analytical method development and validation, stability studi...
Documents:

B-SOW-Attachment-to-Sources-Sought-Notice.pdf

If you are registered member, kindly login to view full details of this tender notice:

Drug Manufacturing and Formulation Program - USA Tender

The HEALTH AND HUMAN SERVICES, DEPARTMENT OF, a Government sector organization in USA, has announced a new tender for Drug Manufacturing and Formulation Program. This tender is published on USARFP under UST Ref No: 95765870 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-02-07.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.